Viewing Study NCT02865434


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-26 @ 1:08 AM
Study NCT ID: NCT02865434
Status: COMPLETED
Last Update Posted: 2021-08-12
First Post: 2016-08-05
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA
Sponsor: Navidea Biopharmaceuticals
Organization: